[1] Albain KS,Green SJ,Ravdin PM,et al. Adjuvant chemohormonal therapy for primary breast cancer should be given sequential instead of concurrent: Initial results from Intergroup trial 0100(SWOG-88-14). J Clin Oncol,2002,21:37.
[2] Pico C,Martin M,Jara C,et al. Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase Ⅲ trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study. Ann Oncol,2004,15:79-87.
[3] Lin NU,Winer EP. Advances in adjuvant endocrine therapy for postmenopausal women. J Clin Oncol,2008,26:798-805.
[4] Early breast cancer trialists′ collaborative group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet,1998,351:1451-1467.
[5] Fowble B,Fein DA,Hanlon AL,et al. The impact of tamoxifen on breast recurrence,cosmesis,complications,and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys,1996,35:669-677.
[6] National institutes of health consensus development conference statement. Adjuvant therapy for breast cancer,November 1-3,2000. J Natl Cancer Inst Monogr,2001,30:5-15.
[7] Osborne C,Boldt D,Clark G,et al. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res,1983,43:3583-3585.
[8] Wazer DE,Tercilla OF,Lin PS,et al. Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen. Br J Radiol,1989,62:1079-1083.
[9] Bhning K,Busch M,Rave-Frank M,et al. Effect of tamoxifen and estrogen treatment on the radiosensitivity of MCF-7 breast cancer cells. Onkologie,1996,19:163-169.
[10] Sutherland RL,Taylor IW,Reddel RR,et al. Effects of tamoxifen on the cell cycle kinetics of human mammary carcinoma cells in culture. J Cell Biochem,1982,6:1034.
[11] Newton CJ,Schlatterer K,Stalla GK,et al. Pharmacological enhancement of radiosurgery response: studies on an in vitro model system. J Radiosurg,1998,1:51.
[12] Singla R,Albuquerque K,Creech S,et al. The presence and timing of tamoxifen and its effect on the radiosensitivity of MCF-7 breast cancer cells. Breast Cancer Res Treat,2003,82:161.
[13] Ellis PA,Saccani-Jotti G,Clarke R,et al. Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer,1997,72:608-613.
[14] Fodor J. Interactions between radiation and hormonal therapy in breast cancer: simultaneous or sequential treatment. Orv Hetil,2006,147:121-125.
[15] Inano H,Onoda M. Prevention of radiation-induced mammarytumors. Int J Radiat Biol,2002,52:212-23.
[16] Inano H,Onoda M,Suzuki K,et al. Prevention of radiation induced mammary tumours in rats by combined use of W R-2721 and tamoxifen. Int J Radiat Biol,2002,76:1113.
[17] Azia D,Larbouret C,Cunat S,et al. Letrozole sensitizes aromatase-expressing breast tumour cells to gamma irradiation. Breast Cancer Res Treat,2003,82:41.
[18] Paulsen G,Strickert T,Marthinsen A,et al. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol,1996,35:1011-1019.
[19] Harris EE,Christensen VJ,Hwang WT,et al. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol,2005,23:11-16.
[20] Wazer D,DiPetrillo T,Schmidt-Ulrich R,et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol,1992,10:356-363.
[21] Deutsch M,Flickinger JC. Am edema after lumpectomy and breastirradiation. Am J Clin Oncol,2003,26:229.
[22] Azria D,Gourgou S,Sozzi WJ,et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer,2004,91:1251-1260.
[23] Bentzen SM,Skoczylas JZ,Overgaard M,et al. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst,1996,88:918-922.
[24] Wennberg B,Gagliardi G,Sundbom L,et al. Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys,2002,52:1196-1206.
[25] Koc M,Polat P,Suma S. Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients. Radiother Oncol,2002,64:171-175.
[26] Huang E,Wang C,Chen H,et al. Multivariate analysis of pulmonary fibrosis after electron beam irradiation for postmastectomy chest wall and regional lymphatics: evidence for nondosimetric factors. Radiother Oncol,2000,57:91-96.
[27] Pierce LJ,Hutchins LF,Green SR,et al. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. J Clin Oncol,2005,23:24-29.
[28] Knabbe C,Lippman ME,Wakefield LM,et al. Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell,1987,48:417-428.
[29] Border WA,Noble NA. Transforming growth factor beta in tissuefibrosis. N Engl J Med,1994,331:1286-1292.
[30] Butta A,MacLennan K,Flanders KC,et al. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res,1992,52:4261-464.
[31] Breast international group(BIG) 1-98 collaborative group,Thurlimann B,Keshaviah A,et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med,2005,353:2747-2750.
[32] ATAC trialists′group. Results of the ATAC(arimidex,tamoxifen,alone or in combination) trial after completion of 5 years′ adjuvant treatment for breast cancer. Lancet,2005,365:60-62.
[33] Coombes RC,Hall E,Gibson LJ,et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med,2004,350:1081-1097.
[34] Azria D,Larbouret C,Cunat S,et al. Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Res,2005,7:156-163.
[35] Bollet MA,Kirova YM,Antoni G,et al. Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women. Radiother Oncol,2007,85:336-345.
[36] Azria D,Belkacemi Y,Romieu G,et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer(CO-HO-RT): a phase 2 randomised trial. The Lancet Oncol,2010,11:258-265.
[37] Nakatani K,Matsumoto M,Ue H,et al. Erythema multiforme after radiotherapy with aromatase inhibitor administration in breastconservation treatment for breast cancer. Breast Cancer,2008,15:321-323. |
|
|
2012, Vol. 21 
